| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 31.782 | 44.877 | 48.159 | 62.955 | 77.766 | 101.617 | 109.071 | 129.565 | 183.574 | 207.970 |
| Total Income - EUR | 31.782 | 44.878 | 48.159 | 62.956 | 77.766 | 101.618 | 109.284 | 129.736 | 200.416 | 207.974 |
| Total Expenses - EUR | 17.687 | 31.688 | 42.314 | 45.406 | 45.368 | 61.997 | 58.053 | 55.889 | 57.351 | 81.182 |
| Gross Profit/Loss - EUR | 14.095 | 13.189 | 5.845 | 17.550 | 32.399 | 39.621 | 51.230 | 73.847 | 143.065 | 126.792 |
| Net Profit/Loss - EUR | 13.142 | 12.292 | 4.393 | 16.921 | 31.664 | 38.977 | 50.339 | 72.652 | 141.374 | 121.486 |
| Employees | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 2 |
Check the financial reports for the company - Maroxmed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 34.769 | 62.011 | 46.945 | 32.235 | 20.140 | 74.986 | 64.229 | 55.187 | 128.072 | 186.941 |
| Current Assets | 24.818 | 4.173 | 10.483 | 29.082 | 41.427 | 23.475 | 19.750 | 59.918 | 98.598 | 25.492 |
| Inventories | 0 | 0 | 320 | 975 | 0 | 0 | 0 | 1.372 | 3.170 | 5.660 |
| Receivables | 3.671 | -13 | 2.720 | 2.557 | 5 | 15.378 | 2.888 | 18.682 | 40.340 | 12.860 |
| Cash | 21.147 | 4.186 | 7.443 | 25.550 | 41.422 | 8.096 | 16.863 | 39.864 | 55.088 | 6.972 |
| Shareholders Funds | 40.800 | 43.769 | 42.812 | 49.899 | 48.766 | 53.762 | 72.585 | 59.282 | 199.812 | 195.989 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 62 | 61 | 61 | 61 | 60 |
| Debts | 18.787 | 27.873 | 17.332 | 14.160 | 12.800 | 63.449 | 42.500 | 80.413 | 44.966 | 27.816 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Maroxmed Srl